Other Private Labelers Likely NBTY Suitors – Market Analyst
This article was originally published in The Tan Sheet
Nutritional supplement manufacturer and marketer NBTY would be attractive to other private-label firms outside as well as within the supplement arena, but not to over-the-counter drug firms looking to expand into the field, according to an industry analyst
You may also be interested in...
Nutritional supplement manufacturer and marketer NBTY says a "mix of better selling products" gained "improved product placement" in U.S. markets as its Wholesale/U.S. Nutrition unit's 2007 first-quarter (ended Dec. 31) sales increased $22 million from the year-ago period to $247 million
Its reported worldwide consumer Q4 net sales increased 12.7%, or 16.4% adjusted for currency exchange rates, product launches and other changes from the prior-year period, to $1.1bn. The s results, though, sent share price plummeting $8.64, more than 14%, to $51.82.
UK ASA upholds complaints that questioned claims made in 2018 TV ads that Innovo was clinically proven to strengthen the pelvic floor and treat bladder weakness. In the US, however, claims Atlantic Therapeutics will use to promote OTC sales of Innovo were approved by FDA.